SERES THERAPEUTICS (MCRB) Covered Calls

SERES THERAPEUTICS covered calls Seres Therapeutics Incis a microbiome therapeutics platform company developing a novel class of biological drugs, which are designed to restore health by repairing the function of a dysbiotic microbiome.

You can sell covered calls on SERES THERAPEUTICS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for MCRB (prices last updated Mon 2:10 PM ET):

SERES THERAPEUTICS (MCRB) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
7.87 -0.34 7.85 7.88 36K - 0.3B
Covered Calls For SERES THERAPEUTICS (MCRB)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 7.5 0.65 7.23 3.7% 40.9%
Jan 18 7.5 0.85 7.03 6.7% 40.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Seres Therapeutics, Inc. is a clinical stage biotherapeutic company, which focuses on discovering and developing Ecobiotic therapeutic products to treat important diseases by targeting the underlying biology of the human microbiome. It candidates span metabolic, inflammatory, and infectious diseases. The company drugs are designed to restore health by repairing the function of a dysbiotic microbiome. Seres Health was founded by Geoffrey von Maltzahn, David A. Berry and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.